These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1418090

  • 1. Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP).
    Koren E, Armstrong VW, Mueller G, Wilson PR, Schuff-Werner P, Thiery J, Eisenhauer T, Alaupovic P, Seidel D.
    Atherosclerosis; 1992 Aug; 95(2-3):157-70. PubMed ID: 1418090
    [Abstract] [Full Text] [Related]

  • 2. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM, Alaupovic P, Knight-Gibson C, Dudley VS, Laughlin LO.
    Am J Cardiol; 1995 Jun 01; 75(16):1124-9. PubMed ID: 7762498
    [Abstract] [Full Text] [Related]

  • 3. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr 01; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 4. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC, Austin MA, Moulin P, Wolf AC, Cryer D, Knopp RH.
    Atherosclerosis; 1993 Aug 01; 102(1):107-19. PubMed ID: 8257447
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of apolipoprotein E on cholesteryl ester-enriched low density lipoprotein particles in coronary artery atherosclerosis of hypercholesterolemic nonhuman primates.
    Stevenson SC, Sawyer JK, Rudel LL.
    Arterioscler Thromb; 1992 Jan 01; 12(1):28-40. PubMed ID: 1731856
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein heterogeneity and its effect on apolipoprotein assays.
    Fruchart JC.
    Scand J Clin Lab Invest Suppl; 1990 Jan 01; 198():51-7. PubMed ID: 2111936
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC, Chapman MJ, Bruckert E, Farriaux JP, De Gennes JL.
    Atherosclerosis; 1991 Jan 01; 86(1):69-83. PubMed ID: 1829609
    [Abstract] [Full Text] [Related]

  • 11. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
    Genest JJ, Bard JM, Fruchart JC, Ordovas JM, Wilson PF, Schaefer EJ.
    Atherosclerosis; 1991 Oct 01; 90(2-3):149-57. PubMed ID: 1684707
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes.
    Igau B, Lestavel S, Clavey V, Slomianny C, Drouin P, Bresson R, Fruchart JC, Duriez P, Fiévet C.
    Atherosclerosis; 1996 Feb 01; 120(1-2):209-19. PubMed ID: 8645362
    [Abstract] [Full Text] [Related]

  • 15. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P, Wang CS, McConathy WJ, Weiser D, Downs D.
    Arch Biochem Biophys; 1986 Jan 01; 244(1):226-37. PubMed ID: 3080947
    [Abstract] [Full Text] [Related]

  • 16. Cholesteryl ester transfer protein promotes the association of HDL apolipoproteins A-I and A-II with LDL: potentiation by oleic acid.
    Lagrost L, Barter PJ.
    Biochim Biophys Acta; 1992 Aug 19; 1127(3):255-62. PubMed ID: 1511003
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fluvastatin reduces levels of plasma apo B-containing particles and increases those of LpA-I. European Fluvastatin Study Group.
    Dallongeville J, Fruchart JC, Pfister P, Bard JM.
    Am J Med; 1994 Jun 06; 96(6A):32S-36S. PubMed ID: 8017464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.